Life Sciences Law360 provides breaking legal news and analysis on the
pharmaceutical and medical device industry. Coverage includes high-stakes
litigation and policy developments that affect life sciences companies, as well
as licensing deals, mergers, and other corporate transactions.
Sign up for a 7-day FREE trial today!
Latest News in Life Sciences
-
November 02, 2026
The Delaware Chancery Court last week allowed a stockholder claim over R1 RCM Inc.'s $8.9 billion buyout to proceed, while investors in Meta Platforms Inc. sued to block a stock restructuring they say would let CEO Mark Zuckerberg sell billions of dollars in shares without giving up control of the company.
-
November 02, 2026
Pharmaceutical company Karyopharm Therapeutics Inc. on Monday filed for Chapter 11 protection in a Texas bankruptcy court with $441.5 million in debt and a plan to merge with biotechnology firm Ayrmid Ltd.
-
October 30, 2026
Long-running multidistrict litigation over AbbVie and Teva Pharmaceuticals' agreement to delay generic forms of cholesterol drug Niaspan is headed toward trial, after a Pennsylvania federal judge Friday found a genuine dispute over whether their agreement was a pay-to-delay settlement that violated antitrust laws.
-
October 30, 2026
With former Theranos CEO Elizabeth Holmes' criminal case receiving renewed attention following the recent release of Nathan Fielder and Lance Oppenheim's documentary "You Can See Everything," Law360 answers questions about Holmes' 2022 securities fraud conviction and fact-checks some of the documentary's most talked-about moments.
-
October 30, 2026
A coalition of 23 states and the District of Columbia urged a Rhode Island federal court Friday to let them continue challenging a now-rescinded Trump administration directive to "temporarily" withhold their federal funding, arguing a permanent injunction should still be on the table.
See more Life Sciences news